Frontier Capital Management’s Veradermics MANE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.2M Sell
92,174
-162,702
-64% -$17.8M 0.12% 221
2026
Q2
$31.3M Buy
+254,876
New +$23.9M 0.29% 135

Other funds holding MANE

Frontier Capital Management's MANE Position: Q3 2026 in Review

Frontier Capital Management reduced its Veradermics (MANE) stake by 64% in Q3 2026, selling an estimated $17.8M and leaving 92,174 shares worth $11.2M. The position accounts for 0.12% of the portfolio, ranked #221.

Frontier Capital Management first reported a position in MANE in Q2 2026 and has held it in 2 quarters since. The position peaked at $31.3M in Q2 2026. 208 funds tracked by Wall St. Rank hold MANE as of Q3 2026.

  • Frontier Capital Management held 92,174 shares of Veradermics worth $11.2M as of Q3 2026.
  • Frontier Capital Management sold 162,702 Veradermics shares in Q3 2026, an estimated $17.8M.
  • Veradermics made up 0.12% of Frontier Capital Management's portfolio in Q3 2026, its #221 holding.
  • Frontier Capital Management first reported a position in Veradermics in Q2 2026 and has held it in 2 quarters since.
  • Frontier Capital Management's Veradermics position peaked at $31.3M in Q2 2026.
  • 208 funds tracked by Wall St. Rank held Veradermics as of Q3 2026.

Based on Frontier Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.